Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
about
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisUnmet Needs in LDL-C Lowering: When Statins Won't Do!Risk assessment in the prevention of cardiovascular disease in low-resource settingsDNA Damage: A Main Determinant of Vascular AgingMethodological Challenges in Estimating Trends and Burden of Cardiovascular Disease in Sub-Saharan AfricaApplicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A ReviewEvaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithmsUse of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysisOverview of guidelines for the management of dyslipidemia: EU perspectivesPromoting functional health in midlife and old age: long-term protective effects of control beliefs, social support, and physical exerciseIs prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.Improved cardiovascular risk prediction using nonparametric regression and electronic health record data.Adapting machine learning techniques to censored time-to-event health record data: A general-purpose approach using inverse probability of censoring weightingRepeated measurement of the intermountain risk score enhances prognostication for mortality.Identification of low risk of violent crime in severe mental illness with a clinical prediction tool (Oxford Mental Illness and Violence tool [OxMIV]): a derivation and validation studyEffect of food intake on 92 biomarkers for cardiovascular disease.A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study.An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort studyThe 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of riskPrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Applying measures of discriminatory accuracy to revisit traditional risk factors for being small for gestational age in Sweden: a national cross-sectional study.The Framingham Heart Study's impact on global risk assessmentConsumption of added sugars and indicators of cardiovascular disease risk among US adolescents.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represSeparate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands.Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.Coronary artery calcium score and risk classification for coronary heart disease prediction.Caloric sweetener consumption and dyslipidemia among US adults.Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.Integrating health into cognitive aging: toward a preventive cognitive neuroscience of agingAchievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyAnti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyModern risk stratification in coronary heart disease.Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam.The evolution and refinement of traditional risk factors for cardiovascular disease.Data on coronary artery calcium score performance and cardiovascular risk reclassification across gender and ethnicitiesLow use of statins for secondary prevention in primary care: a survey in a northern Swedish population.Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa
P2860
Q24603648-B5442BA2-83FF-4DA6-A93A-59F37AAAF387Q26741705-D06CBB2C-4F55-42E3-937A-7AE24ED2500CQ26744435-D1DFBCC4-B04F-4869-840C-9390F3C5A28CQ26746962-5C224881-766F-4CED-8FE5-2145593DBD3FQ26772252-7FC91EC3-E73A-4E4E-A982-AEB1D67D056CQ26784142-67A3EFC5-5140-48B3-8769-0BF7711BAB6DQ26864118-4CA25AE6-6676-4DA3-9DBE-EC75076BB5C3Q27007284-6CB4A734-1B6E-4890-B8ED-123CDE33EF20Q28069411-FCAEF484-0E6D-404F-9D5D-CCC1E67DF897Q28475730-9EBF507B-BAD2-4621-B460-40FB11F1025BQ30397875-5FEAB0A7-9B4D-43FB-B27D-171134951DA8Q30583304-1753539E-DDB9-4586-AED0-8B1C04222CA7Q31060694-1D769CDC-74D4-49D4-A5D9-939BBE5BF9D2Q31123541-F2678AF0-5B45-4E77-B1C3-1B4A1DC890A9Q33735072-0CE4B03E-4F6A-4A29-9F22-CCC227742E77Q33769171-2110F94F-D678-49BD-9E9E-ED45CA41F7E5Q33789885-43BC531D-1033-4C64-AAD9-A8F0591F0761Q33848884-468254A5-2645-4173-A55C-458BD47A8329Q33916671-736E0233-5059-4EF7-A824-DDCC4EC5B17CQ33972551-443B8671-A2AF-4A4B-9480-772CE019221BQ33996015-2A659980-49C6-43C2-B4A0-9192E52BDEF7Q33996738-DD384832-7B75-417D-A496-FD2E8304CEB9Q34025295-46D26F65-C6BB-4719-A5C7-8C40EB61C289Q34046881-13FD406C-4C3B-4607-9E65-683581895641Q34170210-C201A578-11AC-4B47-A53C-D826AB23C778Q34207158-A8A14793-3480-4E3E-AFEE-C00D886D6E39Q34364949-54AD0366-374D-40AB-AB53-BEBAAC85E100Q34552221-C7398C1C-3DF8-4875-8A6E-E5D016464242Q34607557-37AFA92C-960A-44D5-B736-D7F3803774DBQ34614614-74A25873-BF99-4374-A8B5-F1262000F4FBQ35094993-E96E2D35-D72D-4AA5-997E-3D5459BB3C34Q35187425-B64A8C31-1B8B-477F-B872-8A9D142B6546Q35373624-76F0A106-E25E-491F-9DCA-69BD7623E47FQ35581714-2D88F4D9-7807-49DE-B3CB-EBE6C40E9595Q35776957-D5E47766-F2C8-4EF1-BCC2-7059BDE28788Q35829944-AC6AA7FC-B922-451C-8269-B9E22BB3B0BFQ35848359-48741A84-6908-4DE0-A9A7-E27368AA8A80Q35933588-C33A4745-8BF6-4EE7-995F-75BBFC5906EBQ36102162-E2BBB771-F418-4E76-B827-0B471FD047B3Q36136807-19F54BD8-697D-49E3-B3C9-E9774C0907AA
P2860
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Value and limitations of exist ...... risk: a review for clinicians.
@en
Value and limitations of exist ...... risk: a review for clinicians.
@nl
type
label
Value and limitations of exist ...... risk: a review for clinicians.
@en
Value and limitations of exist ...... risk: a review for clinicians.
@nl
prefLabel
Value and limitations of exist ...... risk: a review for clinicians.
@en
Value and limitations of exist ...... risk: a review for clinicians.
@nl
P1476
Value and limitations of exist ...... risk: a review for clinicians
@en
P2093
Alexandra L Dudina
Ian M Graham
P304
P356
10.1016/J.JACC.2009.07.020
P407
P577
2009-09-01T00:00:00Z